Clinical Trials Logo

Clinical Trial Summary

The MEOPA is used to obtain an analgesia of the short-term painful acts. To the population of elderly patients, the therapeutic resources to control the passing pain require in their manipulation a certain caution and are not divested of side effects badly tolerated at this age. An alternative in the opioid presents all its interest. The MEOPA is here an alternative of choice in the care of these pains, in particular in case of pre-existent cognitive achievement, of polypathologies or of polymédication.

The gas MEOPA administered to the mask could thus be an effective additive in the physiotherapy treatment of the elderly person.

The main objective is to Assess the efficacy , in terms of recovery of the hip and knee joint articular amplitude, of 3 sessions of reeducation using MEOPA versus standard reeducation within a population of elderly patients presenting a pain during the physiotherapy treatment.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT02230007
Study type Interventional
Source Centre Hospitalier Universitaire de Nice
Contact Véronique MAILLAND, MD
Phone 0033 4 92034397
Email mailland-putegnat@chu-nice.fr
Status Recruiting
Phase Phase 4
Start date June 2013
Completion date July 2015

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06001749 - Psilocybin in Cancer Pain Study Phase 2